SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker - 02/03/22
Doi : 10.1016/j.jinf.2021.10.008
Aayush Gupta a, ⁎, 1 
, Rahul Bhoyar b, 1, Shahzad Mirza a, Bani Jolly b, c, Vigneshwar Senthivel b, c, Afra Shamnath b, Mohit Kumar Divakar b, c, Mohamed Imran b, c, Vishu Gupta b, c, Srashti Jyoti Agrawal b, c, Sahjid Mukhida a, Sridhar Sivasubbu b, c, Vinod Scaria b, c, ⁎
, Rahul Bhoyar b, 1, Shahzad Mirza a, Bani Jolly b, c, Vigneshwar Senthivel b, c, Afra Shamnath b, Mohit Kumar Divakar b, c, Mohamed Imran b, c, Vishu Gupta b, c, Srashti Jyoti Agrawal b, c, Sahjid Mukhida a, Sridhar Sivasubbu b, c, Vinod Scaria b, c, ⁎ a Department of Dermatology, Medical College, Hospital and Research Centre, Pimpri, Pune 411018, India
b CSIR- Institute of Genomics and Integrative Biology, Sukhdev Vihar Mathura Road, New Delhi 110025, India
c Academy for Scientific and Innovative Research, Human Resource Development Centre, Campus, Ghaziabad, Uttar Pradesh 201002, India
⁎Corresponding author.⁎⁎Corresponding authors at: Knowledge Centre for Genome Informatics, CSIR- Institute of Genomics and Integrative Biology, Sukhdev Vihar Mathura Road, New Delhi 110025, India.Knowledge Centre for Genome InformaticsCSIR- Institute of Genomics and Integrative BiologySukhdev Vihar Mathura RoadNew Delhi110025India
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | Symptomatic SARS-CoV-2 infection post natural infection and 2 doses of ChAdOx1. |
• | Moderate levels of antibodies were detected 2 weeks post natural infection. |
• | Patient tested SARS-CoV-2 positive 30 days after the second dose of vaccine. |
• | Genomic analysis confirmed the infection with B.1.617.2 variant of SARS-CoV-2. |
Keywords : SARS-CoV-2, COVID-19, Vaccine breakthrough, Healthcare worker, Whole-genome sequencing
Plan
© 2021
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 3
P. 418-467 - mars 2022 Retour au numéro
Article précédent
- Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
- Olivier Epaulard, Marlyse Buisson, Benjamin Nemoz, Marion Le Maréchal, Nicolas Terzi, Jean-François Payen, Marie Froidure, Myriam Blanc, Anne-Laure Mounayar, Fanny Quénard, Isabelle Pierre, Patricia Pavese, Raphaele Germi, Laurence Grossi, Sylvie Larrat, Pascal Poignard, Julien Lupo
- A meta-analysis of the association between calprotectin and the severity of COVID-19
- Qin Mao, Chunyi Wang, Wen Wen, Mengyun Zhou, Jiake Tang, Chen Chen, Yongran Cheng, Qi Wu, Xingwei Zhang, Zhanhui Feng, Mingwei Wang
Bienvenue sur EM-consulte, la référence des professionnels de santé.